Work

Final results of a phase II study of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic or recurrent squamous cell cancer of the head and neck (SCCHN).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.5592

Authors: George R. Blumenschein, Bonnie S. Glisson, Charles Lu, Anita Lyn Sabichi, Lawrence E. Ginsberg, Claudia I. Bartos, Lei Feng, Hai T. Tran, Adel K. El-Naggar, Scott Michael Lippman, Merrill S. Kies

Institutions: The University of Texas MD Anderson Cancer Center, Baylor College of Medicine

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2244091891

Cites:

Cited by: 23

Related to: 10